Podcast details:
In this episode of IMPACT Medicom’s podcast series on Precision Medicine in Oncology we discuss:
· The evolving role of genomics in a pathologist’s tool kit for informing care in oncology
· The value of comprehensive genomic profiling (CGP) compared to single-gene tests
· The barriers to accessing CGP in Ontario
· What factors institutions should consider when deciding how to implement CGP
Our guest:
Dr. Brandon Sheffield is an anatomical pathologist at William Osler Health System in Brampton, Ontario, where he serves as Medical Director of Immunohistochemistry and Molecular Pathology, and Physician Lead of Research. He received his Doctor of Medicine at the University of Toronto and completed his anatomical pathology residency at the University of British Columbia. Given his interest in molecular genetic pathology, Dr. Sheffield played an integral role in acquiring William Osler’s new rapid comprehensive next generation sequencing technology, making Osler the first community hospital in the world to offer this type of genetic testing in-house for their cancer patients.
Brandon also served as a steering committee member on IMPACT Medicom’s CGP prioritization report. The full report can be downloaded at: https://www.impactmedicom.com/publications/reports
This podcast episode was sponsored by AstraZeneca Canada.
If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com